Health Care/Hospital

111 Unveils New Video on The Impact of Chinese Policies to Medical Industry

SHANGHAI, Jan. 19, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today,The Impact of Chinese Policies to Medical Industry,...

2020-01-19 18:00 18363

Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019

NANPING, China, Jan. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2019. The financial results...

2020-01-17 21:00 19128

111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference

SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation inChina's Healthcare and Pharmaceutical Industry" at the 3...

2020-01-17 20:00 7551

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...

2020-01-16 21:00 6144

"Every Person Deserves the Chance to Live a Healthy and Productive Life" -- 2020 BUTTON Healthcare Cross-Border Partnering Summit -- From Globe to Asia

HEFEI, China, Jan. 16, 2020 /PRNewswire/ -- On the morning of January 13, 2020 (Pacific Time), the 38th J.P. Morgan Healthcare Conference opened in San Francisco as scheduled. At the same time, the "BUTTON Healthcare Cross-Border Partnering Summit - From Globe toAsia" was grandly held at the Merc...

2020-01-16 16:11 1130

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany

* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-01-16 10:39 17961

Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"

SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...

2020-01-16 07:30 1512

GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids

NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the manufacturing service of GMP Plasmids with Genopis, Inc., a company that specializes in plasmid D...

2020-01-16 01:00 2060

Medit Responds to Ongoing Patent Infringement Lawsuit in Germany

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Medit today announced that there is an ongoing lawsuit inGermany in relation to European Patent no. 2 568 870 B1. The Regional Court of Duesseldorf in Germany rendered a judgment on January 9, 2020 (docket number 4c O 11/19), holding that Medit's...

2020-01-14 23:26 1721

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...

2020-01-13 22:00 6485

Volition Develops a New Improved Nu.Q™ Assay Format

AUSTIN, Texas, Jan. 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided an update on its Nu Q™ Clinical Assays which use a magnetic particle-based assay format. Volition has completely re-engineered its Nu.Q™ assays leading to a step-change improvement in...

2020-01-13 22:00 16146

111, Inc. Enters Into Strategic Partnership with Bestyoo to Upgrade Online Healthcare Service Model

SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced that it has entered into a strategic partnership with Bestyoo, a prescription information sharing solutions provider inChina. 111 will wo...

2020-01-13 18:30 5866

Say NO to Food Allergies, Taiwan User-Friendly Sensor & Tech (TFT) Creates Personalized Food Allergen Detection System

LAS VEGAS, Jan. 10, 2020 /PRNewswire/ -- Taiwan User-Friendly Sensor and Tech (TFT) and other notable homegrown startups led by Taiwan Tech Arena (TTA) are now showcasing their innovative solutions at CES 2020.

2020-01-11 00:00 1800

GCAM Adds New Plasma Collection Center

FULLERTON, Calif. and YONGIN, South Korea, Jan. 10, 2020 /PRNewswire/ -- GCAM, Inc., a U.S. based plasma collection company, announced that it has added additional plasma collection centers; located inEdinburg, Texas. With the newest additions, GCAM now runs 12 plasma donation centers nationwide....

2020-01-10 22:00 1756

VolitionRx Completes Acquisition of Octamer GmbH

AUSTIN, Texas, Jan. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the closing of the acquisition of the epigenetic reagent company Octamer GmbH ("Octamer") by its subsidiary Belgian Volition SPRL for approximately$725,000, consisting of cash and sh...

2020-01-10 21:00 15240

Jorjin and Gigabyte Join Forces to Showcase a Smart Pharmacy Solution and a New Family of AR Smart Glasses at CES 2020

LAS VEGAS, Jan. 9, 2020 /PRNewswire/ -- Jorjin Technologies, who started working on smart glasses when AR was still in its infancy, will be partnering with Gigabyteat this year's CES on a joint AR-based end-to-end solution for Smart Pharmacies. Furthermore, Jorjin will also introduceJ-Ability, th...

2020-01-10 02:15 1270

Led by Taiwan Tech Arena, LuftQi Is Committed to Developing Non-Consumable Nano Photocatalytic Purification Technology to Improve Air Quality and Health

LAS VEGAS, Jan. 9, 2020 /PRNewswire/ -- LuftQi and other notable homegrown startups led by Taiwan Tech Arena (TTA) are now showcasing their innovative solutions at CES 2020. With the nano photocatalytic purification technology, the Luft Cu...

2020-01-10 00:30 2125

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global o...

2020-01-09 17:10 2631

The largest full marathon in China:The 2020 C&D Xiamen Marathon starts

XIAMEN, China, Jan. 9, 2020 /PRNewswire/ -- "Falling in love with a city while running". The 2020 C&D Xiamen Marathon started at7:30 a.m. on January 5, with 35,071 runners having qualified, and 29,805 of them joining the event in the flesh. Runners from 41 countries and regions participated in th...

2020-01-09 16:11 1357

Transcenta Holding Secures $100 Million Series B Plus Financing

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...

2020-01-08 21:00 1527